Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5433242 | 0.77 | SCN5A (0.32) | — | |
| SCHEMBL8036904 | 0.65 | ADORA2A (0.32) | — | |
| SCHEMBL7530961 | 0.64 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL8034847 | 0.64 | TKT (0.32) | TKT | |
| SCHEMBL5414289 | 0.63 | CSNK2A1 (0.35) | — | |
| SCHEMBL5402381 | 0.63 | — | — | |
| SCHEMBL2953524 | 0.63 | CYP1A2 (0.42) | CYP1A2 | |
| SCHEMBL11576859 | 0.62 | MAPT (0.54) | CYP1A2 | |
| SCHEMBL12479057 | 0.61 | GAA (0.56) | CYP1A2 | |
| SCHEMBL21960277 | 0.61 | CYP1A2 (0.41) | CYP1A2TKT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0618902-A1 | PROCESS FOR PRODUCING 4,5-DIAMINO PYRAZOLE DERIVATIVES, THEIR USE FOR COLOURING HAIR AND NOVEL PYRAZOLE DERIVATIVES | Wella Aktiengesellschaft (DE) | 1994-10-12 | — | — | EP | claimed |
| WO-1994008969-A1 | PROCESS FOR PRODUCING 4,5-DIAMINO PYRAZOLE DERIVATIVES, THEIR USE FOR COLOURING HAIR AND NOVEL PYRAZOLE DERIVATIVES | WELLA AKTIENGESELLSCHAFT (DE) | 1994-04-28 | — | — | WO | claimed |
| US-20030000027-A1 | Novel colorant combination | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2003-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030000027-A1 | Novel colorant combination | GPX4, PRDX3, NDUFS5 | CYP1A2 157/4885TKT 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.